[(2R)-1-octanoyloxy-3-pentadecanoyloxypropan-2-yl] octadecanoate
C44H84O6 — CID 131810509
Data last refreshed: (MolForge compound catalog, from PubChem)
About [(2R)-1-octanoyloxy-3-pentadecanoyloxypropan-2-yl] octadecanoate
[(2R)-1-octanoyloxy-3-pentadecanoyloxypropan-2-yl] octadecanoate (PubChem CID 131810509) has the molecular formula C44H84O6 and a molecular weight of 709.15 g/mol. Its IUPAC name is [(2R)-1-octanoyloxy-3-pentadecanoyloxypropan-2-yl] octadecanoate.
Molecular Properties
| Compound Name | [(2R)-1-octanoyloxy-3-pentadecanoyloxypropan-2-yl] octadecanoate |
|---|---|
| PubChem CID | 131810509 |
| Molecular Formula | C44H84O6 |
| Molecular Weight | 709.15 g/mol |
| Exact Mass | 708.63 |
| IUPAC Name | [(2R)-1-octanoyloxy-3-pentadecanoyloxypropan-2-yl] octadecanoate |
| SMILES | CCCCCCCCCCCCCCCCCC(=O)O[C@H](COC(=O)CCCCCCC)COC(=O)CCCCCCCCCCCCCC |
| InChI | InChI=1S/C44H84O6/c1-4-7-10-13-15-17-19-21-22-23-25-27-29-32-35-38-44(47)50-41(39-48-42(45)36-33-30-12-9-6-3)40-49-43(46)37-34-31-28-26-24-20-18-16-14-11-8-5-2/h41H,4-40H2,1-3H3/t41-/m1/s1 |
| InChIKey | GJZLPBGJGMHFGN-VQJSHJPSSA-N |
| XLogP | 13.70 |
| TPSA | 78.90 Ų |
| H-Bond Donors | |
| H-Bond Acceptors | 6 |
| Rotatable Bonds | 40 |
| Heavy Atoms | 50 |
| Complexity | — |
Lipinski Rule of Five
2 violations
| Rule | Value |
|---|---|
| MW ≤ 500 | 709.15 |
| LogP ≤ 5 | 13.70 |
| H-Bond Donors ≤ 5 | 0 |
| H-Bond Acceptors ≤ 10 | 6 |
Computed Properties (RDKit)
| Structural Alerts | {'alert_name': '>_2_ester_groups', 'substructure': 'N/A'}, {'alert_name': 'Aliphatic_long_chain', 'substructure': 'N/A'} |
|---|
Frequently Asked Questions
Browse: Molecules A–Z · all molecules A–Z · drugs A–Z · protein targets A–Z.
Sources
- PubChem CID 131810509 — identifiers, structure, computed properties (public domain)
How this page is built: methodology · editorial policy & corrections.
For research and educational use only — not medical advice. This page is compiled automatically from public databases. It is not written or reviewed by a clinician. Do not start, stop or change any treatment based on it; consult a qualified healthcare professional. Spotted an error? See our corrections policy or email hello@molforge.ai.